PMCTPharmaCountry
    ホーム

規制動向

FDA、EMA、TGA および世界の規制動向

#Ranolazine ×

UPDATED
規制動向
2026年9月3日•1分で読めます
FDA Approves ANDA209953 for Ranolazine Extended‑Release Tablets
The FDA has approved ANDA209953 for generic Ranolazine extended‑release tablets (500 mg and 1 g) manufactured by Ascend Laboratories and sponsored by ALKEM LABS.